Sudemycin D6
Sudemycin D6 is a pre-mRNA splicing modulator with potent antitumour activity. Sudemycin D6 changes splice site usage of the DUSP11 and SRRM1 pre-mRNA. Sudemycin D6 reduces survival and alters cell cycle in haematopoietic cells expressing mutant U2AF1. Sudemycin D6 attenuates mutant U2AF1-induced haematopoietic progenitor cell expansion in U2AF1(S34F) transgenic mice. Sudemycin D6 can be used for cancer research.
For research use only. We do not sell to patients.
- CAS No.: 1510837-67-8
- Formula: C27H42N2O5
- Molecular Weight:474.63
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
50 nM
Compound: 3, sudemycin D6
|
Cytotoxicity against human HeLa cells after 72 hrs by CellTiter-Glo assay
Cytotoxicity against human HeLa cells after 72 hrs by CellTiter-Glo assay
|
[PMID: 24325474] |
| JeKo-1 | IC50 |
22 nM
Compound: 3, sudemycin D6
|
Cytotoxicity against human JeKo1 cells after 72 hrs by CellTiter-Glo assay
Cytotoxicity against human JeKo1 cells after 72 hrs by CellTiter-Glo assay
|
[PMID: 24325474] |
| PC-3 | IC50 |
142 nM
Compound: 3, sudemycin D6
|
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter-Glo assay
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter-Glo assay
|
[PMID: 24325474] |
| SK-MEL-2 | IC50 |
39 nM
Compound: 3, sudemycin D6
|
Cytotoxicity against human SK-MEL-2 cells after 72 hrs by CellTiter-Glo assay
Cytotoxicity against human SK-MEL-2 cells after 72 hrs by CellTiter-Glo assay
|
[PMID: 24325474] |
| SK-N-AS | IC50 |
81 nM
Compound: 3, sudemycin D6
|
Cytotoxicity against human SK-N-AS cells after 72 hrs by CellTiter-Glo assay
Cytotoxicity against human SK-N-AS cells after 72 hrs by CellTiter-Glo assay
|
[PMID: 24325474] |
Chemical Information
-
CAS No. 1510837-67-8
-
Molecular Weight 474.63
-
Formula C27H42N2O5
-
SMILES
CNC(O[C@@H](C)/C=C\C(N[C@@H](CC1)CC[C@@H]1C/C=C(C)/C=C/[C@@H]2C[C@@]3(CC(C)(O2)C)CO3)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
References
[1]. Shirai CL, et al. Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome. Nat Commun. 2017 Jan 9;8:14060. [Content Brief]
[2]. Thurman M, et al. Changes in Alternative Splicing as Pharmacodynamic Markers for Sudemycin D6. Biomark Insights. 2017 Sep 12;12:1177271917730557. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)